We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+9.9%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$30.8B
AUM Growth
+$2.83B
(+10%)
Cap. Flow
+$314M
Cap. Flow
% of AUM
1.02%
Top 10 Holdings %
Top 10 Hldgs %
29.43%
Holding
995
New
101
Increased
392
Reduced
278
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$434M |
| 2 |
Estee Lauder
EL
|
+$90.8M |
| 3 |
Visa
V
|
+$90M |
| 4 |
Amphenol
APH
|
+$67.6M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$57.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$409M |
| 2 |
CTXS
Citrix Systems Inc
CTXS
|
+$322M |
| 3 |
Apple
AAPL
|
+$115M |
| 4 |
TotalEnergies
TTE
|
+$31.5M |
| 5 |
Deckers Outdoor
DECK
|
+$27.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.08% |
| 2 | Healthcare | 15.56% |
| 3 | Financials | 11.89% |
| 4 | Industrials | 9.57% |
| 5 | Energy | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Dover
DOV
$26.6B
| $27.5M | 0.09% |
424,948
+910
| +0.2% | +$55.7K |
|
152
Charles River Laboratories
CRL
$11B
| $27.3M | 0.09% |
514,130
+39,503
| +8% | +$1.98M |
|
|
RNET
153
DELISTED
RigNet, Inc.
RNET
| $26.8M | 0.09% |
559,791
+8,911
| +2% | +$364K |
|
|
RRTS
154
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
| $26.7M | 0.09% |
39,625
+485
| +1% | +$321K |
|
|
155
TotalEnergies
TTE
$191B
| $26.5M | 0.09% |
432,361
-529,717
| -55% | -$31.5M |
|
156
McDonald's
MCD
$187B
| $26.2M | 0.09% |
270,014
-6,613
| -2% | -$635K |
|
157
Eaton
ETN
$161B
| $26M | 0.08% |
342,182
+25,339
| +8% | +$1.8M |
|
|
DENN
158
DELISTED
Denny's
DENN
| $26M | 0.08% |
3,612,564
+210,960
| +6% | +$1.43M |
|
159
US Bancorp
USB
$98.7B
| $25.8M | 0.08% |
639,361
+51,944
| +9% | +$1.99M |
|
160
VF Corp
VFC
$6.49B
| $25.2M | 0.08% |
429,426
-31,036
| -7% | -$1.62M |
|
161
iShares MSCI EAFE ETF
EFA
$76.1B
| $24.8M | 0.08% |
369,267
-25,094
| -6% | -$1.64M |
|
|
PCL
162
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
| $24.4M | 0.08% |
524,955
+147,664
| +39% | +$6.76M |
|
|
SGEN
163
DELISTED
Seagen Inc. Common Stock
SGEN
| $24.3M | 0.08% |
609,612
-94,813
| -13% | -$3.87M |
|
164
Enovis
ENOV
$1.5B
| $24M | 0.08% |
218,651
+26,334
| +14% | +$2.64M |
|
165
Vanguard Extended Market ETF
VXF
$30.4B
| $23.7M | 0.08% |
286,599
-13,072
| -4% | -$1.04M |
|
166
Abercrombie & Fitch
ANF
$4.04B
| $23.6M | 0.08% |
716,064
+15,987
| +2% | +$552K |
|
|
AIRM
167
DELISTED
Air Methods Corp
AIRM
| $22.2M | 0.07% |
380,262
+22,662
| +6% | +$1.13M |
|
168
Vanguard FTSE Developed Markets ETF
VEA
$226B
| $22M | 0.07% |
527,483
-57,906
| -10% | -$2.35M |
|
169
Acuity Brands
AYI
$9.79B
| $22M | 0.07% |
201,088
-2,130
| -1% | -$217K |
|
|
CNQR
170
DELISTED
CONCUR TECHNOLOGIES INC
CNQR
| $21.6M | 0.07% |
209,264
+8,701
| +4% | +$880K |
|
171
Abbott
ABT
$175B
| $21.5M | 0.07% |
561,011
-2,655
| -0.5% | -$97.9K |
|
|
UN
172
DELISTED
Unilever NV New York Registry Shares
UN
| $21.2M | 0.07% |
525,976
+102,395
| +24% | +$3.98M |
|
173
Enpro
NPO
$7.12B
| $20.6M | 0.07% |
357,482
+47,130
| +15% | +$2.7M |
|
174
TriMas Corp
TRS
$1.44B
| $20.2M | 0.07% |
636,879
-65,922
| -9% | -$2M |
|
|
BRS
175
DELISTED
Bristow Group, Inc.
BRS
| $20M | 0.07% |
266,839
+38,537
| +17% | +$3.01M |
|
Similar funds
QCM
Brown Advisory's Q4 2013 Portfolio in Review
As of Q4 2013, Brown Advisory held 995 positions worth $30.8B, up 10% from $28B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Brown Advisory's Q4 2013 filing shows 101 new, 392 increased, 278 reduced and 51 closed positions. Its largest new stake was Plains GP Holdings: 157,910 shares worth $11.3M. The largest sale was Idexx Laboratories, an estimated $409M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q4 2013 buy was Plains GP Holdings: 157,910 shares worth $11.3M.
- Brown Advisory added most to Gilead Sciences in Q4 2013, an estimated $434M increase.
- Brown Advisory's biggest Q4 2013 reduction was Idexx Laboratories, cutting an estimated $409M.
- Brown Advisory fully exited Ariad Pharmaceuticals Inc in Q4 2013, selling an estimated $19.5M.
- Brown Advisory's ten largest holdings make up 29% of its $30.8B portfolio in Q4 2013.
- Brown Advisory opened 101 new positions and closed 51 in Q4 2013.
- Brown Advisory's portfolio value rose 10% quarter-over-quarter to $30.8B.
Based on Brown Advisory's 13F filing for Q4 2013, filed 11 Feb 2014.